Kirandip Kaur
Primary Care · West Sacramento, CANPI 1104425818
Payments from drug & device makers
Across 84 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$255
- Lilly USA, LLC$240
- Novo Nordisk$234
- Pfizer$166
- Amgen$97
- Johnson & Johnson$92
- plus $664 from 17 others
What the payments were for
- Food & beverage$1,748100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $255 |
| Lilly USA, LLC | 11 | $240 |
| Novo Nordisk | 10 | $234 |
| Pfizer | 9 | $166 |
| Amgen | 6 | $97 |
| Johnson & Johnson | 4 | $92 |
| Dexcom, Inc. | 3 | $89 |
| Sanofi-aventis U.S. LLC | 4 | $83 |
| Boehringer Ingelheim | 3 | $76 |
| Bayer | 3 | $73 |
| Hologic Sales And Service, LLC | 2 | $49 |
| AstraZeneca | 3 | $48 |
| GSK | 2 | $48 |
| Phadia US Inc. | 2 | $39 |
| Cranial Technologies, Inc | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Exact Sciences | 1 | $21 |
| Averitas Pharma Inc. | 1 | $20 |
| Alk-abello, Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Medtronic | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $6 |
How this compares
$1,748 in reported general payments places this provider in the 80th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $13,737 |
| EliquisApixaban | 13 | $10,609 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $949 |
| Levothyroxine Sodium | 36 | $395 |
| Atorvastatin Calcium | 52 | $389 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $349 |
| Fluticasone Propionate | 31 | $326 |
| Omeprazole | 22 | $290 |
| Metformin Hcl | 39 | $287 |
| Lisinopril | 34 | $240 |
| Hydroxyzine Hcl | 26 | $236 |
| Simvastatin | 19 | $235 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 20 | $233 |
| ClopidogrelClopidogrel Bisulfate | 13 | $184 |
| Gabapentin | 16 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $76 | $13,73711 claims |
| PfizerEliquis | $166 | $10,60913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 706 primary care providers in California.
Other primary care in West Sacramento
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.